Cargando…
Drug Efficacy Monitoring in Pharmacotherapy of Multiple Sclerosis With Biological Agents
Multiple sclerosis is a heterogenous disease. Although several EMA-approved disease-modifying treatments including biopharmaceuticals are available, their efficacy is limited, and a certain percentage of patients are always nonresponsive. Drug efficacy monitoring is an important tool to identify the...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Therapeutic Drug Monitoring
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538300/ https://www.ncbi.nlm.nih.gov/pubmed/28328761 http://dx.doi.org/10.1097/FTD.0000000000000393 |